NEUROCRINE BIOSCIENCES INC Increase (Decrease) in Deferred Liabilities
NEUROCRINE BIOSCIENCES INC (NBIX) reported Increase (Decrease) in Deferred Liabilities of $351.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2019-02-08
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was -$44.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for the quarter ending 2018-03-31 was -$28.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for the quarter ending 2017-12-31 was -$28.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for the quarter ending 2017-09-30 was $1.47M.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for fiscal 2018 was $351.00K, a 70.82% decline from fiscal 2017.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for fiscal 2017 was $1.20M.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for fiscal 2016 was -$294.00K.
- NEUROCRINE BIOSCIENCES INC increase (decrease) in deferred liabilities for fiscal 2015 was -$16.00K, a 214.29% decline from fiscal 2014.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $351.00K 10-K · filed 2019-02-08 | |||
| 2018-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$72.00K 10-Q · filed 2018-07-31 | -$100.00K derived: sum of 3 quarters · filed 2019-02-08 | $1.37M derived: sum of 4 quarters · filed 2019-02-08 |
| 2018-03-31 | -$28.00K 10-Q · filed 2018-04-30 | -$56.00K derived: sum of 2 quarters · filed 2019-02-08 | $1.41M derived: sum of 3 quarters · filed 2019-02-08 | $1.29M derived: sum of 4 quarters · filed 2019-02-08 |
| 2017-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | $1.44M derived: sum of 2 quarters · filed 2019-02-08 | $1.32M derived: sum of 3 quarters · filed 2019-02-08 | $1.20M 10-K · filed 2019-02-08 |
| 2017-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.34M derived: sum of 2 quarters · filed 2018-07-31 | $1.23M 10-Q · filed 2017-11-01 | $1.15M derived: sum of 4 quarters · filed 2019-02-08 |
| 2017-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$239.00K 10-Q · filed 2018-07-31 | -$325.00K derived: sum of 3 quarters · filed 2019-02-08 | -$397.00K derived: sum of 4 quarters · filed 2019-02-08 |
| 2017-03-31 | -$114.00K 10-Q · filed 2018-04-30 | -$200.00K derived: sum of 2 quarters · filed 2019-02-08 | -$272.00K derived: sum of 3 quarters · filed 2019-02-08 | -$344.00K derived: sum of 4 quarters · filed 2019-02-08 |
| 2016-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-08 | -$158.00K derived: sum of 2 quarters · filed 2019-02-08 | -$230.00K derived: sum of 3 quarters · filed 2019-02-08 | -$294.00K 10-K · filed 2019-02-08 |
| 2016-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$144.00K derived: sum of 2 quarters · filed 2017-11-01 | -$208.00K 10-Q · filed 2017-11-01 | -$249.00K derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$136.00K 10-Q · filed 2017-08-03 | -$177.00K derived: sum of 3 quarters · filed 2018-02-13 | -$205.00K derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | -$64.00K 10-Q · filed 2017-05-09 | -$105.00K derived: sum of 2 quarters · filed 2018-02-13 | -$133.00K derived: sum of 3 quarters · filed 2018-02-13 | -$53.00K derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$69.00K derived: sum of 2 quarters · filed 2018-02-13 | $11.00K derived: sum of 3 quarters · filed 2018-02-13 | -$16.00K 10-K · filed 2018-02-13 |
| 2015-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $52.00K derived: sum of 2 quarters · filed 2016-11-02 | $25.00K 10-Q · filed 2016-11-02 | $20.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $53.00K 10-Q · filed 2016-08-03 | $48.00K derived: sum of 3 quarters · filed 2017-02-14 | $55.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | -$27.00K 10-Q · filed 2016-05-05 | -$32.00K derived: sum of 2 quarters · filed 2017-02-14 | -$25.00K derived: sum of 3 quarters · filed 2017-02-14 | -$19.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.00K derived: sum of 2 quarters · filed 2017-02-14 | $8.00K derived: sum of 3 quarters · filed 2017-02-14 | $14.00K 10-K · filed 2017-02-14 |
| 2014-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $13.00K derived: sum of 2 quarters · filed 2015-10-29 | $19.00K 10-Q · filed 2015-10-29 | $46.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $12.00K 10-Q · filed 2015-07-29 | $39.00K derived: sum of 3 quarters · filed 2016-02-11 | $78.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-03-31 | $6.00K 10-Q · filed 2015-04-30 | $33.00K derived: sum of 2 quarters · filed 2016-02-11 | $72.00K derived: sum of 3 quarters · filed 2016-02-11 | $110.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2013-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $66.00K derived: sum of 2 quarters · filed 2016-02-11 | $104.00K derived: sum of 3 quarters · filed 2016-02-11 | $142.00K 10-K · filed 2016-02-11 |
| 2013-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $77.00K derived: sum of 2 quarters · filed 2014-11-04 | $115.00K 10-Q · filed 2014-11-04 | $182.00K derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $76.00K 10-Q · filed 2014-08-06 | $143.00K derived: sum of 3 quarters · filed 2015-02-09 | $222.00K derived: sum of 4 quarters · filed 2015-02-09 |
| 2013-03-31 | $38.00K 10-Q · filed 2014-05-01 | $105.00K derived: sum of 2 quarters · filed 2015-02-09 | $184.00K derived: sum of 3 quarters · filed 2015-02-09 | $263.00K derived: sum of 4 quarters · filed 2015-02-09 |
| 2012-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09 | $146.00K derived: sum of 2 quarters · filed 2015-02-09 | $225.00K derived: sum of 3 quarters · filed 2015-02-09 | $305.00K 10-K · filed 2015-02-09 |
| 2012-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $158.00K derived: sum of 2 quarters · filed 2013-10-29 | $238.00K 10-Q · filed 2013-10-29 | $340.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | $159.00K 10-Q · filed 2013-07-26 | $261.00K derived: sum of 3 quarters · filed 2014-02-11 | $378.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2012-03-31 | $80.00K 10-Q · filed 2013-05-02 | $182.00K derived: sum of 2 quarters · filed 2014-02-11 | $299.00K derived: sum of 3 quarters · filed 2014-02-11 | $415.00K derived: sum of 4 quarters · filed 2014-02-11 |
| 2011-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $219.00K derived: sum of 2 quarters · filed 2014-02-11 | $335.00K derived: sum of 3 quarters · filed 2014-02-11 | $434.00K 10-K · filed 2014-02-11 |
| 2011-09-30 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $233.00K derived: sum of 2 quarters · filed 2012-10-31 | $332.00K 10-Q · filed 2012-10-31 | $493.00K derived: sum of 4 quarters · filed 2013-02-08 |
| 2011-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | $215.00K 10-Q · filed 2012-07-31 | $376.00K derived: sum of 3 quarters · filed 2013-02-08 | |
| 2011-03-31 | $99.00K 10-Q · filed 2012-05-02 | $260.00K derived: sum of 2 quarters · filed 2013-02-08 | ||
| 2010-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08 | $680.00K 10-K · filed 2013-02-08 | ||
| 2010-09-30 | $519.00K 10-Q · filed 2011-10-31 | |||
| 2009-12-31 | $796.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |